Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilateral Greater Occipital Nerve Block for Headache Secondary to Spontaneous Subarachnoid Hemorrhage
2025-520619-15-00Phase 2Authorised
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in subarachnoid hemorrhage (SAH) and nontraumatic subarachnoid hemorrhage (SAH) comparing Lidocaine GON block with Saline placebo GON block (2 arms). Primary endpoint: Headache response at 1 hour post-procedure. Planned start May 2025; status: authorised.
02
Drugs
lidocaine
03
Conditions
subarachnoid hemorrhage (SAH)nontraumatic subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2025-520619-15-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520619-15-00.